THE BASIC PRINCIPLES OF LDN-27219 CANCER TREATMENT RESEARCH

1 particularly interesting compound is LDN-27219. Though most tTG inhibitors are meant to bind to your protein crosslinking active web page, LDN-27219 as a substitute binds on the nucleotide binding pocket from the enzyme though it is actually in its closed-condition conformation, and stabilizes that conformation to stop crosslinking activity.seven